✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹430 Cr.
P/E
632.10
  • Kerala Ayurveda
  • Aayush Wellness
  • Brooks Laboratories
FAQs on Kerala Ayurveda Ltd. Shareprice

Kerala Ayurveda has given better returns compared to its competitors.
Kerala Ayurveda has grown at ~33.2% over the last 6yrs while peers have grown at a median rate of 20.69%

Kerala Ayurveda is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Kerala Ayurveda is 632, while 3 year average PE is 39.48.
Also latest EV/EBITDA of Kerala Ayurveda is 59.19 while 3yr average is 61.92.

Growth Table
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Balance Sheet
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Cash Flow
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Quarterly Results
  • Kerala Ayurveda Ltd.
  • Aayush Wellness
  • Brooks Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on Kerala Ayurveda Ltd. Financials

Balance sheet of Kerala Ayurveda is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Kerala Ayurveda is increasing.
Latest debt of Kerala Ayurveda is ₹56.21 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹24.07 Crs.

The profit is oscillating.
The profit of Kerala Ayurveda is ₹1.51 Crs for TTM, -₹1.56 Crs for Mar 2024 and -₹0.53 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kerala Ayurveda latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech